Abstract:Background Many ophthalmologists have proved that the intravitreal injection of plasmin can safely induce posterior vitreous detachment(PVD),but if it can generate the complete PVD need further to seek confirmation.Researches showed that the safe dose and toxicity dose of dispase are very near,so its application is limited.Whether hyaluronidase can induce PVD is still in controversy.Objective This study is to clarity the mechanism of pharmacological vitreolysis with plasmin and hyaluronidase.Methods Plasmin 4μmol/L,2μmol/L and 1μmol/L,plasmin 1μmol/L+ hyaluronidase 20μmol/L,hyaluronidase alone were intravitreally injected in lateral eye of 4 clean New Zealand white rabbits respectively,and 0.1mL BSS was injected as control group.Electron immunocytochemical technique was used to detect the laminin and fibronectin of interface between vitreous and retina in 7 days after intravitreal injection.Other 14 eyes of 7 clean New Zealand white rabbits were used in this study.Plasmin 1μmol/L + hyaluronidase 20μmol/L was intravitreally injected in the lateral eyes,and only plasmin 1μmol/L was injected in the fellow eyes.Plasmin activity in vitreous was evaluated in 15 and 30 minutes,1 hour,2,3,6,12 hours after intravitreal injection.The use of animals followed the Regulations for the Administration of Affair Concerning Experimental Animals by State Science and Technology Commission.Results The amounts of laminin and fibronectin in the vitreoretinal interface were decreased in 4μmol/L plasmin group,2μmol/L plasmin group,1μmol/L plasmin group,1μmol/L plasmin+20μmol/L hyaluronidase group compared with control group(P＜0.01).No significant difference was seen in the density of gold particles of anti FN between 20μmol/L hyaluronidase group and control group (P＞0.05).The change of amounts of fibronectin in the vitreoretinal interface was similar to that of laminin.Plasmin activity remained the highest level 1 hour after injection and thereafter gradually decreased and extincted in 12 hours and presented the same trend between plasmin 1μmol/L+hyaluronidase 20μmol/L group and only plasmin 1μmol/L group.Conclusion The mechanism of pharmacological vitreolysis is to dissolve laminin and fibronectin in the interface between vitreous and retina and therefore induce PVD.Combination of plasmin with hyaluronidase can increase the efficiency of pharmacological vitreolysis.The optimum selection of drug in inducing PVD should consider not only its role of lysis laminin and fibronectin but also the role of liquefying the vitreous. Key words: plasmin; hyaluronidase; pharmacological vitreolysis; etiology

Research advances on enzymatic vitreolysis

Research Advances on Assisted Drug Induced Posterior Vitreous Detachment

Enzyme-induced Vitreolysis Can Alleviate the Progression of Diabetic Retinopathy Through the HIF-1α Pathway.

Ultrastructure Research of Posterior Vitreous Detachment

Vitreoretinal complications of uveitis: The role of vitrectomy

Progress in prevention and treatment of traumatic proliferative vitreoretinopathy

Vitreous Function and Intervention of It with Vitrectomy and Other Modalities

The Current Status of Biomaterials As Vitreous Substitutes

Vitreous Substitutes: The Present and the Future

Advances in vascular endothelial growth factor antagonist therapy for ocular neovascularization diseases

The Effect Mechanism of Pharmacological Vitreolysis with Plasmin and Hyaluronidase

Enzymatic vitreolysis with recombinant microplasminogen and tissue plasminogen activator.

The new functions of vitreous:to maintain vitreous oxygen tension,and its association with ocular diseases

Vitreoschisis‐induced vitreous cortex remnants in proliferative vitreoretinopathy: A comprehensive review from basic research to clinical practice

Proliferative vitreoretinopathy: an update on the current and emerging treatment options

PVD following plasmin but not hyaluronidase: implications for combination pharmacologic vitreolysis therapy.

Recent Advances in Hydrogels: Ophthalmic Applications in Cell Delivery, Vitreous Substitutes, and Ocular Adhesives

Vitreous Wiping, a new technique for removal of vitreous cortex remnants during vitrectomy

Polymeric hydrogel as a vitreous substitute: current research, challenges, and future directions

Effects of enzymatic degradation on dynamic mechanical properties of the vitreous and intravitreal nanoparticle mobility

Desired properties of polymeric hydrogel vitreous substitute